In this study, we demonstrate MLT specifically targets the overexpressed NRP-1 receptor in fibrotic tissue, implementing dual inhibition of the TGF-β/Smad and MAPK pathways and ultimately blocking EndMT in PF. The gene discussed is TGFB1; the disease is pemphigus foliaceus.